CoChat
Sign Up
Cited by 465Diabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular HealthLipid metabolism and disorders

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.

Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia

Open access
Parhofer, Klaus G.·2015·Diabetes & Metabolism Journal
DOI 10.4093/dmj.2015.39.5.353PMC PMC4641964
Open this paper in CoChat — free accountOpen PDF

Abstract

Glucose and lipid metabolism are linked to each other in many ways. The most important clinical manifestation of this interaction is diabetic dyslipidemia, characterized by elevated triglycerides, low high density lipoprotein cholesterol (HDL-C), and predominance of small-dense LDL particles. However, in the last decade we have learned that the interaction is much more complex. Hypertriglyceridemia and low HDL-C cannot only be the consequence but also the cause of a disturbed glucose metabolism. Furthermore, it is now well established that statins are associated with a small but significant increase in the risk for new onset diabetes. The underlying mechanisms are not completely understood but modulation of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG CoA)-reductase may play a central role as genetic data indicate that mutations resulting in lower HMG CoA-reductase activity are also associated with obesity, higher glucose concentrations and diabetes. Very interestingly, this statin induced increased risk for new onset type 2 diabetes is not detectable in subjects with familial hypercholesterolemia. Furthermore, patients with familial hypercholesterolemia seem to have a lower risk for type 2 diabetes, a phenomenon which seems to be dose-dependent (the higher the low density lipoprotein cholesterol, the lower the risk). Whether there is also an interaction between lipoprotein(a) and diabetes is still a matter of debate.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4093/dmj.2015.39.5.353

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 High density lipoprotein (HDL) may be linked to glucose metabolism in multiple ways. HDL (at least certain subtypes) have direct anti-inflammatory properties. HDL are also the central component of reverse cholesterol transport and mediate cholesterol efflux from many tissues. This may change the micro environment such that insulin sensitivity and insulin secretion improve.
Fig. 1 High density lipoprotein (HDL) may be linked to glucose metabolism in multiple ways. HDL (at least certain subtypes) have direct anti-inflammatory properties. HDL are also the central component of reverse cholesterol transport and mediate cholesterol efflux from many tissues. This may change the micro environment such that insulin sensitivity and insulin secretion improve.CC BY-NC · PubMed Central
Fig. 2 Animal studies indicate that knock-out and overexpression of apolipoprotein A1 (apoA1) affect many metabolic pathways related to diabetes development [21]. Whether the results observed in rodents are also valid in humans is unknown. HDL, high density lipoprotein; HbA1c, glycosylated hemoglobin.
Fig. 2 Animal studies indicate that knock-out and overexpression of apolipoprotein A1 (apoA1) affect many metabolic pathways related to diabetes development [21]. Whether the results observed in rodents are also valid in humans is unknown. HDL, high density lipoprotein; HbA1c, glycosylated hemoglobin.CC BY-NC · PubMed Central
Fig. 3 Statin therapy is associated with a small increase in new-onset diabetes type 2. The underlying pathophysiology is not well understood. A number of different mechanisms may lead to decreased insulin sensitivity and altered β-cell function. In predisposed subjects this may induce the manifestation of type 2 diabetes. HMG-CoA, 3-hydroxy-3-methylglutaryl-coenzyme A.
Fig. 3 Statin therapy is associated with a small increase in new-onset diabetes type 2. The underlying pathophysiology is not well understood. A number of different mechanisms may lead to decreased insulin sensitivity and altered β-cell function. In predisposed subjects this may induce the manifestation of type 2 diabetes. HMG-CoA, 3-hydroxy-3-methylglutaryl-coenzyme A.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Research works printed but not linked: 1

  1. Vuorio, 2015, J Intern Med

Cited by

Sorted by citations

Items 301–400 of 465

Related

See all

Metadata

Authors
Parhofer, K. G.
Affiliations
Ludwig-Maximilians-Universität München (DE)
Corresponding author
Parhofer, Klaus G.
ORCID
Parhofer, Klaus G.
Venue
Diabetes & Metabolism Journal
Publisher
Korean Diabetes Association
Published
2015
Volume
39
Issue
5
Pages
353
ISSN
  • 2233-6079 (ISSN-L)
  • 2233-6087
DOI
10.4093/dmj.2015.39.5.353
PMC
PMC4641964
OpenAlex
W2114340826
Cited by
458
References
52
Citations by year
2026: 29 · 2025: 61 · 2024: 62 · 2023: 58 · 2022: 48 · 2021: 64 · 2020: 37 · 2019: 33 · 2018: 28 · 2017: 21 · 2016: 16
FWCI
3.28
Type
journal article
Language
en
Open access
Licence
Locations
  • Diabetes & Metabolism Journal (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
diabetic dyslipidemia, hypertriglyceridemia, low HDL cholesterol, small dense LDL, statin-induced diabetes, HMG-CoA reductase, type 2 diabetes, familial hypercholesterolemia, LDL cholesterol, lipoprotein(a), obesity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review